Quantitative immunohistochemical analysis revealed the beneficial effect of BHD treatment on the neurogenesis in the peri-infarct area following ischemic stroke, as evidenced by the elevated cells number of Ki67+, Ki67/MAP-2+ and Ki67/GFAP+. This evidence concerns the gene MAP2 and ischemic stroke.